Antiviral activities of Artemisia vulgaris L. extract against herpes simplex virus
Chinese Medicine - 2023
Tóm tắt
Artemisia vulgaris L. is often used as a traditional Chinese medicine with the same origin of medicine and food. Its active ingredient in leaves have multiple biological functions such as anti-inflammatory, antibacterial and insecticidal, anti-tumor, antioxidant and immune regulation, etc. It is confirmed that folium Artemisiae argyi has obvious anti-HBV activity, however, its antiviral activity and mechanism against herpesvirus or other viruses are not clear. Hence, we aimed to screen the crude extracts (Fr.8.3) isolated and extracted from folium A. argyi to explore the anti-herpesvirus activity and mechanism. The antiherpes virus activity of Fr.8.3 was mainly characterized by cytopathic effects, real-time PCR detection of viral gene replication and expression levels, western blotting, viral titer determination and plaque reduction experiments. The main components of Fr.8.3 were identified by using LC–MS, and selected protein targets of these components were investigated through molecular docking. We collected and isolated a variety of A. vulgaris L. samples from Tangyin County, Henan Province and then screened the A. vulgaris L. leaf extracts for anti-HSV-1 activity. The results of the plaque reduction test showed that the crude extract of A. vulgaris L.-Fr.8.3 had anti-HSV-1 activity, and we further verified the anti-HSV-1 activity of Fr.8.3 at the DNA, RNA and protein levels. Moreover, we found that Fr.8.3 also had a broad spectrum of antiviral activity. Finally, we explored its anti-HSV-1 mechanism, and the results showed that Fr.8.3 exerted an anti-HSV-1 effect by acting directly on the virus itself. Then, the extracts were screened on HSV-1 surface glycoproteins and host cell surface receptors for potential binding ability by molecular docking, which further verified the phenotypic results. LC–MS analysis showed that 1 and 2 were the two main components of the extracts. Docking analysis suggested that compounds from extract 1 might similarly cover the binding domain between the virus and the host cells, thus interfering with virus adhesion to cell receptors, which provides new ideas and insights for clinical drug development for herpes simplex virus type 1. We found that Fr.8.3 has anti-herpesvirus and anti-rotavirus effects. The main 12 components in Fr.8.3 were analyzed by LC–MS, and the protein targets were finally predicted through molecular docking, which showed that alkaloids may play a major role in antiviral activity.
Từ khóa
Tài liệu tham khảo
Karampuri S, Bag P, Yasmin S, Chouhan DK, Bal C, Mitra D, et al. Structure based molecular design, synthesis and biological evaluation of α-pyrone analogs as anti-HSV agent. Bioorg Med Chem Lett. 2012;22(19):6261–6.
Laine RF, Albecka A, van de Linde S, Rees EJ, Crump CM, Kaminski CF. Structural analysis of herpes simplex virus by optical super-resolution imaging. Nat Commun. 2015;6:5980.
McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 1988;69(Pt 7):1531–74.
Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006;12(3):202–11.
Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71(2–3):141–8.
Li W, Wang XH, Luo Z, Liu LF, Yan C, Yan CY, et al. Traditional Chinese medicine as a potential source for HSV-1 therapy by acting on virus or the susceptibility of host. Int J Mol Sci. 2018;19(10):3266.
Richards CM, Case R, Hirst TR, Hill TJ, Williams NA. Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice. J Virol. 2003;77(12):6692–9.
Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ikhevha OJ. Seroprevalence and Co-Infection of Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus (HSV) Among Pregnant Women in Lokoja, North-Central Nigeria. Iran Red Crescent Med J. 2016;18(10):e25284.
Coen DM, Schaffer PA. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov. 2003;2(4):278–88.
Rechenchoski DZ, Faccin-Galhardi LC, Linhares REC, Nozawa C. Herpesvirus: an underestimated virus. Folia Microbiol. 2017;62(2):151–6.
Silva GS, Richards GA, Baker T, Amin PR. Encephalitis and myelitis in tropical countries: Report from the Task Force on Tropical Diseases by the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2017;42:355–9.
Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother. 2011;55(2):459–72.
Brantley JS, Hicks L, Sra K, Tyring SK. Valacyclovir for the treatment of genital herpes. Expert Rev Anti Infect Ther. 2006;4(3):367–76.
Sahu PK, Umme T, Yu J, Nayak A, Kim G, Noh M, et al. Selenoacyclovir and selenoganciclovir: discovery of a new template for antiviral agents. J Med Chem. 2015;58(21):8734–8.
Saijo M, Suzutani T, De Clercq E, Niikura M, Maeda A, Morikawa S, et al. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res. 2002;56(3):253–62.
Szpara ML, Parsons L, Enquist LW. Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J Virol. 2010;84(10):5303–13.
James SH, Prichard MN. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance. Curr Opin Virol. 2014;8:54–61.
Zhang WJ, You CX, Yang K, Chen R, Wang Y, Wu Y, et al. Bioactivity of essential oil of Artemisia argyi Lévl. et Van. and its main compounds against Lasioderma serricorne. J Oleo Sci. 2014;63(8):829–37.
Abad MJ, Bedoya LM, Apaza L, Bermejo P. The Artemisia L. genus: a review of bioactive essential oils. Molecules. 2012;17(3):2542–66.
Song X, Wen X, He J, Zhao H, Li S, Wang M. Phytochemical components and biological activities of Artemisia argyi. J Funct Foods. 2019;52:648–62.
Yoshikawa M, Shimada H, Matsuda H, Yamahara J, Murakami N. Bioactive constituents of Chinese natural medicines. I. New sesquiterpene ketones with vasorelaxant effect from Chinese moxa, the processed leaves of Artemisia argyi Levl. et Vant.: moxartenone and moxartenolide. Chem Pharm Bull. 1996;44(9):1656–62.
Han B, Xin Z, Ma S, Liu W, Zhang B, Ran L, et al. Comprehensive characterization and identification of antioxidants in Folium Artemisiae Argyi using high-resolution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1063:84–92.
Zhang P, Shi B, Li T, Xu Y, Jin X, Guo X, et al. Immunomodulatory effect of Artemisia argyi polysaccharide on peripheral blood leucocyte of broiler chickens. J Anim Physiol Anim Nutr. 2018;102(4):939–46.
Xiao-Yan L, Yuan Z, Long-Bo Z, Da-Hui L, Xian-Zhang H, Li Z, et al. Research progress on chemical constituents from Artemisiae argyi Folium and their pharmacological activities and quality control. Zhongguo Zhong Yao Za Zhi. 2020;45(17):4017–30.
Ge YB, Wang ZG, Xiong Y, Huang XJ, Mei ZN, Hong ZG. Anti-inflammatory and blood stasis activities of essential oil extracted from Artemisia argyi leaf in animals. J Nat Med. 2016;70(3):531–8.
Guan X, Ge D, Li S, Huang K, Liu J, Li F. Chemical composition and antimicrobial activities of Artemisia argyi Lévl. et Vant essential oils extracted by simultaneous distillation-extraction, subcritical extraction and hydrodistillation. Molecules. 2019;24(3):483.
Huang HC, Wang HF, Yih KH, Chang LZ, Chang TM. Dual bioactivities of essential oil extracted from the leaves of Artemisia argyi as an antimelanogenic versus antioxidant agent and chemical composition analysis by GC/MS. Int J Mol Sci. 2012;13(11):14679–97.
Bao X, Yuan H, Wang C, Liu J, Lan M. Antitumor and immunomodulatory activities of a polysaccharide from Artemisia argyi. Carbohydr Polym. 2013;98(1):1236–43.
Hu Q, Liu Z, Guo Y, Lu S, Du H, Cao Y. Antioxidant capacity of flavonoids from Folium Artemisiae argyi and the molecular mechanism in Caenorhabditis elegans. J Ethnopharmacol. 2021;279:114398.
Lv JL, Li ZZ, Zhang LB. Two new flavonoids from Artemisia argyi with their anticoagulation activities. Nat Prod Res. 2018;32(6):632–9.
Nakasugi T, Nakashima M, Komai K. Antimutagens in gaiyou (Artemisia argyi levl. et vant.). J Agric Food Chem. 2000;48(8):3256–66.
Xia JX, Zhao BB, Zan JF, Wang P, Chen LL. Simultaneous determination of phenolic acids and flavonoids in Artemisiae argyi Folium by HPLC-MS/MS and discovery of antioxidant ingredients based on relevance analysis. J Pharm Biomed Anal. 2019;175:112734.
Seo JM, Kang HM, Son KH, Kim JH, Lee CW, Kim HM, et al. Antitumor activity of flavones isolated from Artemisia argyi. Planta Med. 2003;69(3):218–22.
Hu L, Yang X, Yin J, Rong X, Huang X, Yu P, et al. Combination of AgNPs and domiphen is antimicrobial against biofilms of common pathogens. Int J Nanomed. 2021;16:7181–94.
Cui X, Wang Y, Kokudo N, Fang D, Tang W. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010;4(2):39–47.
Tang L, Yan H, Wu W, Chen D, Gao Z, Hou J, et al. Synthesis and anti-influenza virus effects of novel substituted polycyclic pyridone derivatives modified from baloxavir. J Med Chem. 2021;64(19):14465–76.
Looker K, Magaret A, May M, Turner K, Vickerman P, Gottlieb S, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE. 2015;10(10):e0140765.
Kennedy PGE. An overview of viral infections of the nervous system in the immunosuppressed. J Neurol. 2021;268(8):3026–30.
Whitley R. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71:141–8.